Innovation and Equity in an Age of Gene Editing
By Charis Thompson, Ruha Benjamin, Jessica Cussins and Marcy Darnovsky,
The Guardian
| 05. 19. 2015
The first day of BEINGS2015, “A Gathering of Global Thought Leaders to Reach Consensus on the Direction of Biotechnology for the 21st Century”, in Atlanta, coincided with the announcement by the National Academy of Science and National Academy of Medicine of an initiative to look into “promising new treatments for disease,” given that “recent experiments to attempt to edit human genes also have raised important questions about the potential risks and ethical concerns of altering the human germline.”
It is the time of prizes and tussles over intellectual property and experiments on non-viable human embryos, and, calls for caution from CRISPR-CAS9 scientists (here and here and here). Also still in the air is the UK’s political vote, despite an EU consensus against germline genetic modification (was this the first step of ‘Brexit’?) to allow clinics to apply for permission to undertake IVF with mitochondrial DNA donation, a form of germ cell genetic modification that requires egg donation. These technologies are widely considered threshold technologies with unknown and irreversible consequences for individuals, humanity and the environment.
During...
Related Articles
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Darren Incorvaia, Fierce Biotech | 05.28.2025
An international group of gene editing leaders has put out a call for a 10-year ban on heritable human genome editing (HHGE), extending a moratorium that was first proposed in the fallout of a Chinese researcher’s widely decried use of...
Last week, May 21–23, a broad range of experts gathered in Boston to discuss the future of powerful biotechnologies with the potential to change what it means to be human. The fourth in a series of international Summits on human genome editing, this event was organized by the Global Observatory for Genome Editing, which “seeks to expand the range of questions arising at the frontiers of emerging biotechnologies … and fosters international, interdisciplinary, and cross-sectoral dialogue.” Like previous Summits...
By Hannah Devlin, The Guardian | 05.23.2025
The sperm of a man carrying a rare cancer-causing mutation was used to conceive at least 67 children, 10 of whom have since been diagnosed with cancer, in a case that has highlighted concerns about the lack of internationally agreed...